Metropolitan Life Insurance CO Lexicon Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.3 - $3.58 $3,243 - $8,932	2,495 New	2,495 $5,000
Q1 2023 May 15, 2023	SELL	$1.99 - $2.68 $1,213 - $1,634	-610 Reduced 11.72%	4,595 $11,000
Q4 2022 Jun 14, 2023	BUY	$1.8 - $2.56 $1,098 - $1,561	610 Added 13.28%	5,205 $9.94 Million
Q4 2022 Mar 30, 2023	BUY	$1.8 - $2.56 $199 - $284	111 Added 2.18%	5,205 $9,000
Q4 2022 Feb 15, 2023	BUY	$1.8 - $2.56 $199 - $284	111 Added 2.18%	5,205 $9,000
Q3 2022 Jun 14, 2023	BUY	$1.94 - $3.43 $968 - $1,711	499 Added 10.86%	5,094 $12.2 Million
Q3 2022 Mar 30, 2023	SELL	$1.94 - $3.43 $29,171 - $51,576	-15,037 Reduced 74.7%	5,094 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $9,882 - $17,472	5,094 New	5,094 $12,000
Q1 2022 May 12, 2022	SELL	$1.95 - $3.89 $39,255 - $78,309	-20,131 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$3.81 - $6.16 $59,192 - $95,701	15,536 Added 338.11%	20,131 $79,000
Q4 2021 Mar 30, 2023	BUY	$3.81 - $6.16 $2,895 - $4,681	760 Added 3.92%	20,131 $79,000
Q4 2021 Feb 15, 2022	BUY	$3.81 - $6.16 $2,895 - $4,681	760 Added 3.92%	20,131 $79,000
Q3 2021 Jun 21, 2023	BUY	$3.38 - $5.35 $49,942 - $79,051	14,776 Added 321.57%	19,371 $93,000
Q3 2021 Mar 30, 2023	BUY	$3.38 - $5.35 $13,486 - $21,346	3,990 Added 25.94%	19,371 $93,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $65,473 - $103,634	19,371 New	19,371 $93,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $18,457 - $102,437	-15,381 Closed	0 $0
Q2 2019 Jul 12, 2023	BUY	$5.35 - $7.11 $57,705 - $76,688	10,786 Added 234.73%	15,381 $96,000
Q1 2019 Jul 13, 2023	BUY	$4.36 - $7.94 $47,026 - $85,640	10,786 Added 234.73%	15,381 $85,000
Q1 2019 Mar 30, 2023	BUY	$4.36 - $7.94 $44,367 - $80,797	10,176 Added 195.5%	15,381 $85,000
Q1 2019 May 16, 2019	BUY	$4.36 - $7.94 $7,839 - $14,276	1,798 Added 13.24%	15,381 $85,000
Q1 2019 May 15, 2019	SELL	$4.36 - $7.94 $5,131 - $9,345	-1,177 Reduced 7.97%	13,583 $84,000
Q4 2018 Jul 13, 2023	BUY	$6.15 - $10.51 $62,514 - $106,834	10,165 Added 221.22%	14,760 $98,000
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $72,951 - $124,669	11,862 Added 409.32%	14,760 $98,000
Q3 2018 Jul 13, 2023	BUY	$10.32 - $13.06 $104,902 - $132,754	10,165 Added 221.22%	14,760 $157 Million
Q3 2018 Nov 14, 2018	SELL	$10.32 - $13.06 $122,415 - $154,917	-11,862 Reduced 80.37%	2,898 $31,000
Q4 2017 Feb 15, 2018	SELL	$8.77 - $12.28 $161,736 - $226,467	-18,442 Reduced 55.54%	14,760 $146,000
Q2 2017 Aug 14, 2017	BUY	N/A	33,202	33,202 $546,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account